Aliases & Classifications for Esophageal Disease

MalaCards integrated aliases for Esophageal Disease:

Name: Esophageal Disease 12 15
Esophageal Diseases 55 44 73
Esophageal Disorder 76
Ulcer of Esophagus 73
Esophageal Ulcer 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6050
ICD10 33 K22.9
ICD9CM 35 530 530.9
MeSH 44 D004935
NCIt 50 C3027

Summaries for Esophageal Disease

Disease Ontology : 12 A gastrointestinal system disease that is located in the esophagus.

MalaCards based summary : Esophageal Disease, also known as esophageal diseases, is related to barrett esophagus and helicobacter pylori infection, and has symptoms including abdominal pain, constipation and coughing. An important gene associated with Esophageal Disease is ATP12A (ATPase H+/K+ Transporting Non-Gastric Alpha2 Subunit), and among its related pathways/superpathways are MAPK Pathway and Interleukin-4 and 13 signaling. The drugs Lansoprazole and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include the esophagus, lung and testes, and related phenotypes are digestive/alimentary and homeostasis/metabolism

Wikipedia : 76 The esophagus (American English) or oesophagus (British English) (/ɪˈsɒfəɡəs/), commonly known as the... more...

Related Diseases for Esophageal Disease

Diseases related to Esophageal Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 122)
# Related Disease Score Top Affiliating Genes
1 barrett esophagus 30.5 CDX2 GAST PTGS2 TP53
2 helicobacter pylori infection 28.9 CYP2C19 GAST TP53
3 esophagitis, eosinophilic, 1 27.9 ATP12A ATP4A CCL26 EPC2 IL13 IL5
4 esophagitis 27.5 CCL26 CYP2C19 HRH2 IL13 IL5 PTGS2
5 fungal esophagitis 11.0 ATP12A ATP4A
6 bladder calculus 10.9 ATP12A ATP4A
7 neonatal candidiasis 10.9 ATP12A ATP4A
8 acute laryngitis 10.9 ATP12A ATP4A
9 gastroduodenal crohn's disease 10.9 ATP12A ATP4A
10 toxic megacolon 10.9 ATP12A ATP4A
11 postsurgical hypothyroidism 10.9 ATP12A ATP4A
12 gastric antral vascular ectasia 10.9 ATP12A ATP4A
13 rumination disorder 10.8 ATP12A ATP4A
14 laryngeal disease 10.8 ATP12A ATP4A
15 ischemic neuropathy 10.8 ATP12A ATP4A
16 mucoepidermoid esophageal carcinoma 10.8 TP53 WWOX
17 dyskinesia of esophagus 10.8 ATP12A ATP4A TEF
18 esophageal atresia/tracheoesophageal fistula 10.8 ATP12A ATP4A TEF
19 capillary disease 10.8 ATP12A ATP4A
20 squamous papillomatosis 10.8 ATP12A ATP4A WWOX
21 duodenal disease 10.8 ATP12A ATP4A
22 achalasia 10.7
23 paine syndrome 10.7 ATP12A ATP4A TRPV1
24 aspiration pneumonitis 10.7 ATP12A ATP4A HRH2
25 laryngitis 10.7 ATP12A ATP4A HRH2
26 congenital disorder of deglycosylation 10.7 ATP12A ATP4A
27 cytokine deficiency 10.7 IL13 IL5
28 cough variant asthma 10.7 IL5 TRPV1
29 angioimmunoblastic lymphadenopathy with dysproteinemia 10.6 IL13 IL5
30 esophagus adenocarcinoma 10.6 ATP12A ATP4A TP53
31 gastric lymphoma 10.6 ATP12A ATP4A TP53
32 lymph node cancer 10.6 TP53 WWOX
33 respiratory syncytial virus infectious disease 10.6 IL13 IL5
34 aspiration pneumonia 10.5 ATP12A ATP4A TEF TRPV1
35 lymphocytic colitis 10.5 ATP12A ATP4A
36 polyposis, skin pigmentation, alopecia, and fingernail changes 10.5 ATP12A ATP4A CDX2
37 superior mesenteric artery syndrome 10.5 ATP12A ATP4A CDX2
38 inflammatory bowel disease 4 10.4 IL13 IL5
39 photoallergic dermatitis 10.4 ATP12A ATP4A PTGS2
40 gastrointestinal neuroendocrine benign tumor 10.4 ATP12A ATP4A GAST
41 gastric neuroendocrine neoplasm 10.4 ATP12A ATP4A GAST
42 parasitic helminthiasis infectious disease 10.4 IL13 IL5 TRPV1
43 duodenitis 10.4 ATP12A ATP4A GAST
44 granulomatous gastritis 10.4 ATP12A ATP4A GAST
45 paragonimiasis 10.4 IL13 IL5
46 protoplasmic astrocytoma 10.4 PTGS2 TP53
47 hypersensitivity reaction disease 10.4 IL13 IL5 TRPV1
48 ascaris lumbricoides infection 10.4 IL13 IL5 TSLP
49 chronic conjunctivitis 10.4 IL13 IL5 TSLP
50 angiostrongyliasis 10.4 IL13 IL5

Comorbidity relations with Esophageal Disease via Phenotypic Disease Network (PDN): (show all 26)


Active Peptic Ulcer Disease Acute Cystitis
Acute Pancreatitis Bronchitis
Chronic Kidney Failure Decubitus Ulcer
Deficiency Anemia Duodenitis
Dyskinesia of Esophagus Esophageal Cancer
Esophageal Candidiasis Esophageal Varix
Esophagitis Esophagus Carcinoma in Situ
Heart Disease Hypertension, Essential
Intestinal Obstruction Iron Deficiency Anemia
Ischemic Heart Disease Mallory-Weiss Syndrome
Megaesophagus Paralytic Ileus
Peptic Esophagitis Protein-Energy Malnutrition
Schizophreniform Disorder Swallowing Disorders

Graphical network of the top 20 diseases related to Esophageal Disease:



Diseases related to Esophageal Disease

Symptoms & Phenotypes for Esophageal Disease

UMLS symptoms related to Esophageal Disease:


abdominal pain, constipation, coughing, diarrhea, dyspepsia, heartburn, icterus, nausea and vomiting, signs and symptoms, digestive, snoring, tinnitus, sore throat, digestive system symptom, vertigo/dizziness, equilibration disorder, gastrointestinal gas

MGI Mouse Phenotypes related to Esophageal Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 10 HRH2 IL13 IL5 PTGS2 AAAS TP53
2 homeostasis/metabolism MP:0005376 9.83 HRH2 IL13 IL5 PTGS2 AAAS TEF
3 endocrine/exocrine gland MP:0005379 9.81 GAST HRH2 IL13 PTGS2 AAAS TP53
4 neoplasm MP:0002006 9.17 GAST IL5 PTGS2 TP53 TRPV1 CDX2

Drugs & Therapeutics for Esophageal Disease

Drugs for Esophageal Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 681)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 103577-45-3 3883
2
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 137-58-6 3676
3
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 2216-51-5 16666
4
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 15663-27-1 84093 441203 2767
5
Methylene blue Approved, Investigational Phase 4,Not Applicable 61-73-4
6
Terlipressin Approved, Investigational Phase 4,Phase 3,Not Applicable 14636-12-5 72081
7
Irinotecan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 97682-44-5, 100286-90-6 60838
8
Esomeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 161796-78-7, 119141-88-7 4594 9579578
9
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-61-6, 62-31-7 681
10
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 73590-58-6 4594
11
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 102625-70-7 4679
12
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
13
Oxaliplatin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 61825-94-3 5310940 9887054 43805 6857599
14
Propranolol Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 525-66-6 4946
15
Pravastatin Approved Phase 4 81093-37-0 54687
16
Octreotide Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 83150-76-9 383414 6400441
17
Rabeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 117976-89-3 5029
18
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 57808-66-9 3151
19
Docetaxel Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 114977-28-5 148124
20
Carvedilol Approved, Investigational Phase 4,Not Applicable 72956-09-3 2585
21
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 51-43-4 5816
22
Nadolol Approved Phase 4,Phase 3 42200-33-9 39147
23
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
24
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 138530-94-6, 103577-45-3 9578005
25
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-21-8 3385
26
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
27
Fluticasone Approved, Experimental, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 90566-53-3 62924
28
Ethiodized oil Approved, Investigational Phase 4,Phase 3,Not Applicable 8008-53-5
29
Somatostatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 38916-34-6, 51110-01-1 53481605
30
Racepinephrine Approved Phase 4,Phase 2,Not Applicable 329-65-7 838
31
Levoleucovorin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 68538-85-2
32
Alginic acid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 9005-32-7
33
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
34
Nicotine Approved Phase 4,Not Applicable 54-11-5 942 89594
35
Remifentanil Approved Phase 4 132875-61-7 60815
36
Famotidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 76824-35-6 3325
37
Nizatidine Approved Phase 4,Phase 3 76963-41-2 3033637
38
Dobutamine Approved Phase 4 34368-04-2 36811
39
Budesonide Approved Phase 4,Phase 3,Phase 2,Not Applicable 51333-22-3 63006 5281004
40
Nortriptyline Approved Phase 4,Phase 2,Phase 3 72-69-5 4543
41
Methylnaltrexone Approved Phase 4 83387-25-1, 916055-93-1 6603824
42
Norepinephrine Approved Phase 4 51-41-2 439260
43
Phenylephrine Approved Phase 4,Phase 2 59-42-7 6041
44
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
45
Ranitidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 66357-59-3, 66357-35-5 3001055
46
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
47
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Not Applicable 50-24-8 5755
48
Acetaminophen Approved Phase 4,Phase 1,Not Applicable 103-90-2 1983
49
ethanolamine oleate Approved Phase 4,Phase 3 2272-11-9
50
Metoclopramide Approved, Investigational Phase 4,Phase 3,Not Applicable 364-62-5 4168

Interventional clinical trials:

(show top 50) (show all 2507)
# Name Status NCT ID Phase Drugs
1 Effect of Magnesium Alginate on Gastroesophageal Reflux in Infants. Unknown status NCT02806453 Phase 4
2 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4 omeprazole+domperidone SR;omeprazole
3 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
4 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance Unknown status NCT01503476 Phase 4
5 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
6 The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding Unknown status NCT02385422 Phase 4 Carvedilol;Propranolol
7 Personalized Peroral Endoscopic Myotomy for Achalasia Unknown status NCT01570621 Phase 4
8 Primary Prevention of Gastric Variceal Bleeding : Endoscopic Treatment Versus Non-selective Beta-blocker Unknown status NCT01298271 Phase 4 propranolol
9 Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis Unknown status NCT02759393 Phase 4 Dexlansoprazole;Lansoprazole
10 Preventing Recurrent Bleeding After Eradication of Esophageal Varices Unknown status NCT02740166 Phase 4 propranolol
11 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances Unknown status NCT02277886 Phase 4 sodium alginate;esomeprazole
12 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4 dexlansoprazole
13 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
14 Postoperative Pain Management After Minimally Invasive Esophagectomy Unknown status NCT02042313 Phase 4
15 Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices Unknown status NCT01970748 Phase 4 Propranolol
16 Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer Unknown status NCT01038154 Phase 4 Pravastatin
17 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery Unknown status NCT00790140 Phase 4
18 A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma Unknown status NCT00642239 Phase 4 placebo;Sodium Glycididazole
19 Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer Unknown status NCT00628784 Phase 4
20 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
21 Opioids and Esophageal Function Completed NCT01012960 Phase 4 methylnaltrexone
22 Caustic Esophageal Burns in Children and High Doses of Methylprednisolone Completed NCT02002078 Phase 4 methylprednisolon
23 Opioid Effects on Swallowing and Esophageal Sphincter Pressure Completed NCT01191645 Phase 4 naloxone;remifentanil;Sodium Chloride;metoclopramide
24 Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding Completed NCT00966355 Phase 4 Terlipressin;Somatostatin;Octreotide
25 Evaluation of Patients With Non-cardiac Chest Pain Completed NCT00476398 Phase 4
26 Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy Completed NCT00526331 Phase 4
27 Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy Completed NCT01874535 Phase 4 Esomeprazole 40 mg
28 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4 CRH
29 Esophageal Fully Covered Metal Stents in Caustic Strictures Study Completed NCT01899300 Phase 4
30 WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture Completed NCT01699542 Phase 4
31 Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed Completed NCT00644735 Phase 4 Esomeprazole;Lansoprazole
32 A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Completed NCT00641602 Phase 4 Esomeprazole;Lansoprazole
33 Intravenous (IV) Pantoprazole in Erosive Esophagitis Completed NCT00133770 Phase 4 pantoprazole
34 A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices Completed NCT00799851 Phase 4 cyanoacrylate injection
35 Barrett's Esophagus - 315 - 3 Way Cross Over Completed NCT00637988 Phase 4 Esomeprazole;Aspirin;Rofecoxib
36 Barrett's Esophagus - 315 - 3 Way Cross-Over Completed NCT00637559 Phase 4 Esomeprazole Magnesium
37 An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients Completed NCT00352261 Phase 4 Esomeprazole;Lansoprazole
38 Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding Completed NCT02504723 Phase 4 carvedilol;cyanoacrylate
39 Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke Completed NCT02473432 Phase 4
40 Hemodynamic Effects of Terlipressin and High Dose Octreotide Completed NCT02119884 Phase 4 Terlipressin;Octreotide
41 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
42 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
43 Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
44 Time Interval for Endoscopic Variceal Ligation Completed NCT01291277 Phase 4
45 Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B Completed NCT03128736 Phase 4 Esomeprazole group;Dexlansoprazole group
46 The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity Completed NCT02958046 Phase 4 Lansoprazole/Domperidone
47 The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity Completed NCT02689999 Phase 4 Dexrabeprazole 10 mg Enteric-Coated Tablets
48 Role of Pepsin Assay in Wheezy Infants Completed NCT02685436 Phase 4 Omeprazole and domperidone
49 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Completed NCT02351960 Phase 4 Dexlansoprazole
50 Safety and Efficacy of Lansoprazole in Patients With Reflux Disease Completed NCT01135368 Phase 4 Lansoprazole

Search NIH Clinical Center for Esophageal Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: esophageal diseases

Genetic Tests for Esophageal Disease

Anatomical Context for Esophageal Disease

The Foundational Model of Anatomy Ontology organs/tissues related to Esophageal Disease:

19
The Esophagus

MalaCards organs/tissues related to Esophageal Disease:

41
Lung, Testes, Lymph Node, Liver, T Cells, Breast, Bone

Publications for Esophageal Disease

Articles related to Esophageal Disease:

(show top 50) (show all 166)
# Title Authors Year
1
Unsedated in Office Transgastrostomy Esophagoscopy (TGE) to Monitor Therapy in Pediatric Esophageal Disease. ( 28505050 )
2017
2
To anchor or not to anchor self-expanding metal stents in malignant esophageal disease: Is this still a question? ( 29090244 )
2017
3
Can We Use Diet to Effectively Treat Esophageal Disease? A Review of the Current Literature. ( 28730507 )
2017
4
Utility of esophageal mucosal impedance as a diagnostic test for esophageal disease. ( 28437259 )
2017
5
Evolution in the Treatment of Esophageal Disease at a Single Academic Institution: 2004-2013. ( 28486000 )
2017
6
Emerging endoscopic techniques for the identification of esophageal disease. ( 26753504 )
2016
7
Incidence, reasons, and risk factors for readmission after surgery for benign distal esophageal disease. ( 27365228 )
2016
8
An unusual cause of dysphagia: Isolated IgG 4-related esophageal disease. ( 28000632 )
2016
9
Literature Analysis of the Treatment of Benign Esophageal Disease with Stent. ( 27186033 )
2016
10
Understanding the sensory irregularities of esophageal disease. ( 26890720 )
2016
11
Palliation of Concomitant Tracheobronchial and Esophageal Disease Using a Combined Airway and Esophageal Approach. ( 27157053 )
2016
12
Functional lumen imaging probe: the functional lumen imaging probe side of esophageal disease. ( 27030931 )
2016
13
Advances in the evaluation and management of esophageal disease of systemic sclerosis. ( 25475597 )
2015
14
Preface. Esophageal disease. ( 25965140 )
2015
15
Foreword. Esophageal disease. ( 25965139 )
2015
16
Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease. ( 25202116 )
2014
17
Diet and esophageal disease. ( 25266021 )
2014
18
IgG4-Related Esophageal Disease Presenting as Esophagitis Dissecans Superficialis With Chronic Strictures. ( 24883156 )
2014
19
Time trends of US hospitalization for esophageal disease. ( 24440940 )
2014
20
Eosinophilic esophagitis: an immune-mediated esophageal disease. ( 23579771 )
2013
21
Esophageal disease. ( 23948187 )
2013
22
Screening pre-bariatric surgery patients for esophageal disease with esophageal capsule endoscopy. ( 24115815 )
2013
23
Esophageal disease. ( 23990483 )
2013
24
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. ( 24117631 )
2013
25
Redo laparoscopic repair of benign esophageal disease. ( 22608677 )
2012
26
Glycomic expression in esophageal disease. ( 24957772 )
2012
27
Comparison of 2 expandable stents for malignant esophageal disease: a randomized controlled trial. ( 22726466 )
2012
28
Expandable stents for benign esophageal disease. ( 21684459 )
2011
29
Fully covered self-expandable metal stents for benign esophageal disease: a multicenter retrospective case series of 31 patients. ( 21549373 )
2011
30
Esophageal disease in pediatrics. ( 21950832 )
2011
31
Esophageal disease and pathology. ( 21950829 )
2011
32
Esophageal disease: updated information on inflammation. ( 21950828 )
2011
33
Expandable stents for malignant esophageal disease. ( 21684460 )
2011
34
Endoluminal therapy for esophageal disease: an introduction. ( 19951790 )
2010
35
The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. ( 19856027 )
2010
36
Helicobacter pylori and esophageal disease: wake-up call? ( 21029801 )
2010
37
Recent advances in the use of stents for esophageal disease. ( 19951797 )
2010
38
Surgical therapy for esophageal disease: lessons from a master. ( 20494006 )
2010
39
This issue reviews all aspects of endosurgical technologies and devices that encompass endoluminal therapy for esophageal disease. Preface. ( 19951789 )
2010
40
High-resolution manometry: is it better for detecting esophageal disease? ( 21103442 )
2010
41
Benign esophageal disease in the elderly. ( 20066944 )
2009
42
Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. ( 19441788 )
2009
43
Detecting esophageal disease with second-generation capsule endoscopy: initial evaluation of the PillCam ESO 2. ( 18389444 )
2008
44
Esophageal disease. Screening and surveillance for Barrett's esophagus: esophageal capsule versus conventional endoscopy. ( 18477971 )
2008
45
Diagnosis and management of esophageal disease. ( 19107102 )
2008
46
How to keep the treatment of esophageal disease in the surgeon's hands. ( 18222212 )
2008
47
Esophageal disease in progressive systemic sclerosis. ( 21063865 )
2008
48
Intestinal interposition for benign esophageal disease. ( 21063863 )
2008
49
Polyflex expandable stents in the treatment of esophageal disease: initial experience. ( 18498804 )
2008
50
Esophageal capsule endoscopy in patients with suspected esophageal disease: double blinded comparison with esophagogastroduodenoscopy and assessment of interobserver variability. ( 18058656 )
2008

Variations for Esophageal Disease

Expression for Esophageal Disease

Search GEO for disease gene expression data for Esophageal Disease.

Pathways for Esophageal Disease

Pathways related to Esophageal Disease according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.64 IL13 IL5 TP53
2 11.55 IL13 PTGS2 TP53
3 11.35 IL13 IL5 TP53
4 11.23 IL13 IL5 TSLP
5 10.64 IL13 IL5 TSLP
6 9.5 ATP4A GAST HRH2

GO Terms for Esophageal Disease

Biological processes related to Esophageal Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.73 IL13 IL5 PTGS2 TP53
2 cellular sodium ion homeostasis GO:0006883 9.46 ATP12A ATP4A
3 cellular potassium ion homeostasis GO:0030007 9.4 ATP12A ATP4A
4 microglial cell activation GO:0001774 9.37 IL13 TRPV1
5 regulation of signaling receptor activity GO:0010469 9.35 CCL26 GAST IL13 IL5 TSLP
6 sodium ion export across plasma membrane GO:0036376 9.32 ATP12A ATP4A
7 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.26 ATP12A ATP4A
8 cellular response to ATP GO:0071318 9.16 PTGS2 TRPV1
9 inflammatory response GO:0006954 9.02 CCL26 IL13 IL5 PTGS2 TRPV1

Molecular functions related to Esophageal Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.26 CCL26 IL13 IL5 TSLP
2 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP12A ATP4A
3 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP12A ATP4A

Sources for Esophageal Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....